// App-Quantinova.ai

OC10.02 : Development of a core outcome set for studies on uterus sparing treatments of adenomyosis (COSAR): an international consensus study

Researchers

Presenter

  • T. Tellum

Principal Investigators

  • J. Naftalin

  • C. Chapron

  • M. Dueholm

  • S. Guo

  • M. Hirsch

  • E.R. Larby

  • M.G. Munro

  • E. Saridogan

  • Z. Van Der Spuy

  • D. Jurkovic

Medical Centers

  • Department of Obstetrics and Gynecology, Aarhus University Hospital, Aarhus, Denmark

  • Norwegian Endometriosis Association, Oslo, Norway

  • Department of Gynecology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, CA, USA

  • Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Fudan University, Shanghai, China

  • University of Cape Town Faculty of Health Sciences, Observatory, Western Cape, South Africa

  • Department of Gynecology, University College London Hospitals, London, United Kingdom

  • Department of Gynecology, Obstetrics II and Reproductive Medicine, Paris Déscartes University, Paris, France

  • Department of Gynecology, Oslo University Hospital, Oslo, Norway

  • Institute for Women'sHealth, University College London, London, United Kingdom

  • Department of Gynecology, University of Oxford, Oxford, United Kingdom

Locations

  • Denmark

  • Norway

  • United States

  • China

  • South Africa

  • United Kingdom

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

Disease

  • Adenomyosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved